{
    "clinical_study": {
        "@rank": "16492", 
        "arm_group": [
            {
                "arm_group_label": "sevoflurane and saline infusion", 
                "arm_group_type": "No Intervention", 
                "description": "After induction of general anesthesia, Group S received a placebo infusion of normal saline."
            }, 
            {
                "arm_group_label": "sevoflurane and 0.5 \u03bcg/kg dexmedetomidine", 
                "arm_group_type": "Experimental", 
                "description": "After induction of general anesthesia, Group DEX1 received a single dexmedetomidine dose of 0.5 \u03bcg/kg over 10 minutes."
            }, 
            {
                "arm_group_label": "sevoflurane and 1 \u03bcg/kg dexmedetomidine", 
                "arm_group_type": "Experimental", 
                "description": "After induction of general anesthesia, Group DEX2 received a single dexmedetomidine dose of 1 \u03bcg/kg over 10 minutes."
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators designed a double-blind, randomized placebo-controlled study to determine\n      the effects of dexmedetomidine on the recovery characteristics of patients who were\n      scheduled to undergo endovascular coil embolization."
        }, 
        "brief_title": "A Better Choice for Patients Undergoing Endovascular Coil Embolization", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Intracranial Aneurysms", 
        "condition_browse": {
            "mesh_term": [
                "Aneurysm", 
                "Intracranial Aneurysm"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:18-65 years old ASA I or ASA II patients undergoing ECE treatment for\n        intracranial aneurysms were included.\n\n        Exclusion Criteria:Patients were excluded based on the following parameters: older than 65\n        yrs, a history of mental illness, recent use of sedatives or analgesics and with\n        sensation."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01722409", 
            "org_study_id": "20121009"
        }, 
        "intervention": [
            {
                "arm_group_label": "sevoflurane and 0.5 \u03bcg/kg dexmedetomidine", 
                "description": "After induction of general anesthesia, Group DEX1 received a single dexmedetomidine dose of 0.5 \u03bcg/kg over 10 minutes.", 
                "intervention_name": "sevoflurane and 0.5 \u03bcg/kg dexmedetomidine", 
                "intervention_type": "Drug", 
                "other_name": "DEX1"
            }, 
            {
                "arm_group_label": "sevoflurane and 1 \u03bcg/kg dexmedetomidine", 
                "description": "After induction of general anesthesia, Group DEX2 received a single dexmedetomidine dose of 1 \u03bcg/kg over 10 minutes.", 
                "intervention_name": "sevoflurane and 1 \u03bcg/kg dexmedetomidine", 
                "intervention_type": "Drug", 
                "other_name": "DEX2"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Sevoflurane", 
                "Dexmedetomidine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "dexmedetomidine, endovascular coil embolization", 
        "lastchanged_date": "March 17, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Shenyang", 
                    "country": "China", 
                    "state": "Liaoning", 
                    "zip": "110001"
                }, 
                "name": "Wen-fei Tan"
            }
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "3", 
        "official_title": "Sevoflurane, Laryngeal Mask Airway and Single-dose Dexmedetomidine: A Better Choice for Patients Undergoing Endovascular Coil Embolization", 
        "overall_official": {
            "affiliation": "Dept. of Anesthesiology, the First Hospital of CMU", 
            "last_name": "Hong Ma, M.D.,PhD.", 
            "role": "Study Chair"
        }, 
        "overall_status": "Suspended", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The time from termination of the general anesthetic to the time that the patient's eyes opened.  Anesthesiologists collected information on emergence agitation, postoperative nausea and vomiting for 24 hours after the surgery.", 
            "measure": "Observing the recovery characteristics of patients who were scheduled to undergo endovascular coil embolization.", 
            "safety_issue": "Yes", 
            "time_frame": "At the end of the operation and 24 hours later"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01722409"
        }, 
        "responsible_party": {
            "investigator_affiliation": "China Medical University, China", 
            "investigator_full_name": "Wen-fei Tan", 
            "investigator_title": "Associate professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "China Medical University, China", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "China Medical University, China", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013", 
        "why_stopped": "No patients enrolled until now"
    }
}